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Hospital performance, presented as the comparison of averagemeasurements, dismisses
that hospital outcomes may vary across types of patients. We aim at drawing out the rele-
vance of accounting for patient heterogeneity when reporting on hospital performance.
Methods
An observational study on administrative data from virtually all 2009 hospital admissions for
Acute Myocardial Infarction (AMI) discharged in Denmark, Portugal, Slovenia, Spain, and
Sweden. Hospital performance was proxied using in-hospital risk-adjustedmortality. Multi-
level RegressionModelling (MLRM) was used to assess differences in hospital perfor-
mance, comparing the estimates of random intercept modelling (capturing hospital general
contextual effects (GCE)), and random slopemodelling (capturing hospital contextual
effects for patients with and without congestive heart failure -CHF). The weighted Kappa
Index (KI) was used to assess the agreement between performance estimates.
Results
We analysed 46,875 admissions of AMI, 6,314 with coexistent CHF, discharged from 107
hospitals. The overall in-hospital mortality rate was 5.2%, ranging from 4% in Sweden to
6.9% in Portugal. The MLRMwith random slope outperformed the model with only random
intercept, highlighting a much higher GCE in CHF patients [VPC = 8.34 (CI95% 4.94 to
13.03) and MOR = 1.69 (CI95% 1.62 to 2.21) vs. VPC = 3.9 (CI95% 2.4 to 5.9), MOR of







Citation: Comendeiro-Maaløe M, Estupiñán-
Romero F, Thygesen LC, Mateus C, Merlo J,
Bernal-Delgado E, et al. (2020) Acknowledging the
role of patient heterogeneity in hospital
outcome reporting: Mortality after acute
myocardial infarction in five European countries.
PLoS ONE 15(2): e0228425. https://doi.org/
10.1371/journal.pone.0228425
Editor: Timir Paul, East Tennessee State University,
UNITED STATES
Received: October 7, 2019
Accepted: January 14, 2020
Published: February 6, 2020
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0228425
Copyright:© 2020 Comendeiro-Maaløe et al. This
is an open access article distributed under the
terms of the Creative Commons Attribution
License, which permits unrestricted use,
distribution, and reproduction in any medium,
provided the original author and source are
credited.
1.42 (CI95% 1.31 to 1.54) without CHF]. No agreement was observed between estimates
[KI = -0,02 (CI95% -0,08 to 0.04].
Conclusions
The different GCE in AMI patients with and without CHF, along with the lack of agreement in
estimates, suggests that accounting for patient heterogeneity is required to adequately char-
acterize and report on hospital performance.
1. Introduction
The growing availability and use of administrative data are resulting in a profusion of health-
care performance assessment initiatives worldwide. Either institutionally framed or developed
under the umbrella of research projects, the wealth of administrative data offers the opportu-
nity to access larger samples of patients, covering virtually all providers in a health plan, allow-
ing cross-country comparisons and most importantly, enabling the systematic and continuous
monitoring of providers’ performance. Many institutional-based [1–7] and research-oriented
examples [8–15] illustrate this enormous potential. On the other hand, as performance assess-
ment is increasingly deemed to be the basis for different value-based initiatives (e.g. bench-
marking strategies, pay for performance schemes, patient choice programs, etc), decision
makers are increasingly calling for trustworthy measurements and reliable reporting [16].
In this respect, analytical methods play a critical role. Once the use of ordinary (single level)
regression models were shown to be inappropriate, as they circumvent the interdependence of
patient outcomes within a hospital (i.e. patient risk within a hospital is more alike than patient
risk from a different hospital) [9, 12, 15–19], and are at risk of the Yule-Simpson paradox [20],
marginal models (Generalized Estimating Equations, GEE) or multilevel modelling (MLRM)
have become increasingly popular, although their approach and interpretation are clearly dif-
ferent; while the use of GEE focus on the estimation of the population-averaged risk of death
adjusting hospitals’ heterogeneity, MLRM assumes that each hospital has their own underlying
risk of an event, and this risk varies across hospitals (i.e. the probability of an event is condi-
tional to the place where the patient is treated). Accordingly, MLRM has been suggested as a
more appropriate approach when hospital-specific interpretations are needed [21].
But most importantly, variations in hospital performance are usually presented as the com-
parison of adjusted average measures, excluding the possibility that hospital performance may
also be conditioned by patient heterogeneity, for example, determining the care responses to
specific subgroups of patients [22]. One fundamental feature of MLRM in hospital perfor-
mance assessment is that MLRM can drop the assumption that the underlying risk for an indi-
vidual is the same for all hospitals, allowing this risk to vary at hospital level; therefore, the
hospital effect also becomes a function of patient heterogeneity [23]. In practical terms, this
property, which implies the inclusion of random slopes, allows the development of specific
performance measurements for subgroups of patients. Therefore, the observation of better or
worse performance will refer not just to the hospital outcome obtained for the regular patient
but also to the hospital achievement for specific subgroups of individuals. This well-known
property of MLRM has scarcely been exploited in the assessment and reporting of hospital
performance.
In this paper, we use MLRM to draw out the relevance of accounting for patient heteroge-
neity when reporting on hospital performance, using in-hospital mortality in acute myocardial
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infarction as a case study. Including a random slope for AMI patients with coexistent CHF will
show the relevance of accounting for patient heterogeneity in hospital performance reporting.
2. Methods
2.1. Design, population and setting
An observational cross-sectional study utilising administrative data representing virtually all
hospital admissions for AMI in patients aged from 40 to 80, treated in 434 hospitals from 5
European countries (Denmark, Portugal, Slovenia, Spain and Sweden) in 2009, totalling
73,812 potential discharged episodes. Hospitals accounting for fewer than 250 AMI episodes
in 2009 (discretionary threshold) were excluded from the sample in order to reduce structural
heterogeneity across hospitals and gain robustness in the estimations (Fig 1). The final sample
accounted for 107 hospitals, accounting for 46,875 AMI episodes (63.5% of all assisted epi-
sodes), from which 5.2% deceased (2,451 case-fatalities). CHF coexisted in 13,5% of the sample
(6,314 AMI episodes).
2.2. Endpoints
Our work comprised two consecutive endpoints; firstly, the variation in the hospital effect (i.e.
GCE) when including a random slope for CHF patients in the MLRM; and, additionally, the level
of agreement in hospital outcomes, contrasting both types of hospital GCE (i.e. under the assump-
tion that the underlying risk for an individual level association is the same for all the hospitals or
under the assumption that the underlying risk for CHF patients varies across hospitals).
2.3. Variables in the models
As aforementioned, the hospital outcome in this study (i.e. proxy of performance measure) was
the adjusted in-hospital mortality risk in AMI patients who stayed for up to 30 days after admis-
sion; thus, inpatients with admission diagnosis code 410� in those countries using ICD-MC 9th
(Spain and Portugal) and I21� and I22� in those countries using ICD 10th (Denmark, Slovenia
and Sweden). Those admissions due to pregnancy, puerperium or childbirth were excluded
(codes ICD-MC 9th O00�-O99� or ICD10th 630–677). [detailed in S1 Appendix]
The patient-level independent variables were: a) age, categorized as 40–49, 50–59, 60–69
and 70–80, using the youngest group as the reference group; b) sex, using male as the reference
Fig 1. Study population. Flow diagram showing the episodes with an Acute myocardial infarction diagnosis
according to hospital selection.
https://doi.org/10.1371/journal.pone.0228425.g001
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category; c) patient comorbidities, computed as an Elixhauser risk score [24, 25], obtained
from the predicted probability of death for each of the episodes modelled with a single level
logistic regression; and d) the coexistence of congestive heart failure (CHF) in the episode of
AMI. Patients with CHF constituted the subgroup of patients of interest, being more fragile
than the regular patient and supposedly with the requirement for a higher intensity of care. A
CHF was flagged when ICD9th codes 398.91 and 428�, and ICD10th code I50�, were found in
any secondary diagnosis recorded within the same episode. The definitions and corresponding
codes were developed and validated in the context of the ECHO project [26]. When it comes
to the hospital-level, no specific variables where included except the GCE captured as a ran-
dom-effect. Finally, a dummy variable identifying the country of admission was included
using Sweden as a reference in the comparisons.
2.4. Analyses
Upon the estimation of the basal risk of death associated to patient features and country of res-
idence (basal model) throughout a conventional single level logistic regression model includ-
ing age, sex, the Elixhauser score of risk, the coexistence of CHF, and the country of
“treatment” (see variable definitions above), two MLRM models were built to estimate the hos-
pital-specific risk of death for patients with AMI. For that purpose, we followed the methodol-
ogy described elsewhere in a two-stage process [15].
The first MLRM specification included a random intercept for the hospital level in a two-
level multilevel logistic regression model, so that each hospital got its own intercept (i.e. basal
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The second MLRM specification, as an extension of the previous one, included a random
slope, allowing each hospital to vary their risk slope according to a specific group of patients
(in our case, patients with CHF). In practice, we obtain a hospital variance for patients without
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Xnj are the N variables characterising the gender and age of patients









Dj are dichotomous variables which identify the countries where hospitals belong
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2.4.1. Estimation of the general contextual effect. The GCE was estimated for both mod-
els, the random intercept model and the extended model which adds a random slope. For both
models, the hospital variance derivatives, the Variance Partition Coefficient (VPC) and the
Median Odds Ratio (MOR), were also calculated.







Where s2u denotes the hospital variance, and
p2
3
the variance of a standard logistic distribu-
tion (π = 3.1416).
VPC is reported as a percentage that goes from 0% to 100%. If hospital differences (i.e. vari-
ance) were not relevant for understanding the individual differences in the latent propensity of
death, the VPC would be 0%. That is, the hospitals would be similar to random samples taken
from the whole patient population.
(ii) The median odds ratio (MOR) is an alternative interpretation of the magnitude of hos-
pital variance [28–30]. The MOR is defined as the median value of the distribution of odds
ratios (OR) obtained when randomly picking two patients with the same covariate values from
two hospitals with a different underlying risk of an event of interest, and comparing the one
from the hospital with the higher risk to the one from the hospital with the lower-risk. In sim-
ple terms, the MOR can be interpreted as the median increased odds of reporting the outcome






where F−1(�) represents the inverse cumulative standard normal distribution function. In the
absence of hospital variation (i.e. s2u ¼ 0), the MOR is equal to 1. Theoretically, the MOR val-
ues may extend from 0 to1 and the higher the MOR value, the more relevant the hospital
effect in terms of patient outcome. The MOR translates the hospital variance estimated on the
log-odds scale to the widely used OR scale, making MOR values comparable to the individual
OR covariates in the model.
For the estimation of the models, we used the Restricted Iterative Generalized Least Squares
(RIGLS) method to obtain the values needed to finally run the Markov Chain Monte Carlo
(MCMC) estimation method [31]. The goodness-of-fit of the models was assessed through the
Bayesian Diagnostic Information Criterion (BDIC).
We performed the analyses using MLwiN run on Stata1 statistical software: Release 13,
College Station, TX: StataCorp LP and MlwiN version 2.35, The Centre for Multilevel Model-
ling, University of Bristol [32].
2.4.2. Concordance in hospital performance. Finally, for the assessment of concordance
(i.e. agreement in hospital performance on patients with and without CHF), we compared the
residuals from both random parts in the extended model, the intercept [uoj] and the slope
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[u2j]. The level of concordance between both residuals was studied using a measurement of
agreement between observers for categorical variables. As the number of cases per country var-
ied substantially, a weighted Kappa Index was estimated [33]. The choice of this estimator
depends on how commonly performance measurements are reported through funnel plots, so
units of analysis are categorized as: hospitals with residuals which are statistically above the
average (i.e. exhibiting a higher risk of death than expected), hospitals with residuals which are
statistically below the average (i.e. exhibiting a lower risk of death than expected), and hospitals
that did not differ statistically from the expected risk of death, irrespective of their actual posi-
tion above or below (i.e. hospitals within the funnel boundaries). According to this approach,
hospitals in the sample were classified into three possible situations: better, neutral or worse
than the expected, this categorization becoming the subject of the concordance measurement.
As for interpretation purposes, the higher the Kappa Index, the higher the concordance
between the two estimated hospital effects, which could suggest that hospitals perform equally
in the patients without CHF as in the patients with CHF. Conversely, low concordance could
suggest that hospitals perform differently.
2.5. Data sources
Hospital admissions from Denmark, Portugal, Slovenia and Spain were extracted from the
database consolidated and validated during the ECHO project [30]. In turn, the Swedish
Patient Register [34, 35] provided the hospital data for Sweden. Both pseudonymised datasets
were linked into a single database, stored, validated and analysed in a secure server set up in
the premises of the Faculty of Medicine at Lund University (Malmo, Sweden), as foreseen in
the access policies of the Swedish Register.
2.6. Ethics statement
This study, observational in design, used retrospective anonymized, non-identifiable and non-
traceable data, and was conducted in accordance with the amended Helsinki Declaration, the
International Guidelines for Ethical Review of Epidemiological Studies, and Spanish laws on
data protection and patients’ rights. The study implies the use of pseudonymised data, using
double dissociation (i.e. in the original data source and once the data are stored in the database
for analysis) which actually impedes patients’ re-identification. The information supplied for
the European collaboration presented the same strong characteristics of confidentiality as the
other collaborating countries.
3. Results
The final sample was composed of 46,875 episodes with a primary admission diagnosis of
AMI, discharged from 107 hospitals. Overall, 6,314 patients underwent a concomitant CHF.
By countries, Denmark treated 4,635 of those AMI episodes in 6 hospitals (9.9% of the epi-
sodes in the sample); Portugal accounted for 6,217 from 16 hospitals (13.3% of the episodes),
while Slovenia yielded 1,898 episodes in 3 of the hospitals (4.1% of the admissions analysed).
In turn, Spain treated 23,043 AMI episodes in 56 hospitals (49.2% of the episodes in the sam-
ple) while Sweden dealt with 11,082 of the AMI episodes in 26 hospitals (23.6% of the
episodes).
The sample had 38.2% of patients aged 70 to 80, varying across countries, with 33.2% in
Denmark and 42.5% in Sweden. Overall, 26.4% of the patients were female, ranging from
23.6% in Spain to 30.6% in Sweden. The average risk score (i.e. predicted probability of death
according to the Elixhauser comorbidities) for the whole sample was 5.2, ranging from 4.5 in
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Denmark to 5.8 in Portugal. Finally, the overall proportion of AMI patients with congestive
heart failure was 59%, ranging from 56% in Portugal to 79% in Slovenia (Table 1).
Overall, 5.3 per 100 AMI patients died in hospital (2,451 cases out of 46,875) in the period
of study; the crude mortality rate ranged from 0.5 to 13.1 per 100 patients at risk, for an inter-
quartile interval of 1.63. By countries, Sweden, Slovenia and Denmark showed the lowest in-
hospital mortality rates, 4, 4.2 and 4.8 per 100 patients at risk respectively, while Portugal
showed the highest with 6.91 per 100 patients at risk, followed by Spain with an in-hospital
mortality rate of 5.6 per 100 patients at risk (Table 1).
Table 2 shows the estimated adjusted-risks of death in the basal model, the basic GCE and
the extended RS model. As observed in the basal model, the AMI risk of death increased with
age (as compared to patients younger than 50), with the highest risk amongst the oldest (4.8
times more likely to die), the presence of comorbidities (2.1 times more likely), and the coexis-
tence of CHF (2.8 times more likely). As compared to Sweden, patients living in Portugal were
at 78% more risk of death, Denmark and Spain showing a 36% increased risk, while Slovenia
barely registered a 6% increase. Being female did not increase the risk of death. Patient-level
and country-level estimates were similar in both MLRM (second and third column in
Table 2).
Both MLRM models confirmed the existence of a GCE; thus, beyond individuals’ features,
we observed an increase in the risk of death associated to the hospital of treatment. Moreover,
in the specific case of the extended model with a random slope (the best model according to
BDIC), the GCE was much higher in CHF patients, [VPC of 8.34 (CI95% 4.94 to 13.03) and a
MOR value of 1.69 (CI95% 1.62 to 2.21)] than in those without CHF [VPC = 3.9 (CI95% 2.4 to
5.9), MOR of 1.42 (CI95% 1.31 to 1.54)].
Table 1. Description of the study sample, per country (2009).
DNK PRT SVN ESP SWE TOTAL
AMI patients (n) 4,635 6,217 1,898 23,043 11,082 46,875
Age distribution
% patients in age group 40–49 11.28% 11.57% 10.75% 12.51% 6.41% 10.75%
% patients in age group 50–59 22.37% 22.33% 26.45% 22.21% 17.08% 21.20%
% patients in age group 60–69 33.12% 28.55% 27.34% 27.65% 34.03% 29.80%
% patients in age group 70–80 33.23% 36.56% 35.46% 37.63% 42.48% 38.24%
Sex—Percentage of women 26.11% 28.57% 29.72% 23.65% 30.64% 26.44%
Risk Score (mean) 4.51 5.77 5.55 5.47 4.67 5.23
minimum 4.16 4.16 4.16 4.16 4.16 4.16
maximum 68.09 73.04 57.75 76.85 68.34 76.85
CHF patients per hospital (mean)� 78 56 79 58 57 59
minimum 38 19 35 13 28 13
maximum 114 141 117 197 139 197
Deceased (n) 206 432 84 1,286 443 2,451
In-hospital Crude Mortality Rate (per 100 patients at risk in 2009) 4.82 6.91 4.16 5.63 3.99 5.34
minimum 2.83 3.72 1.77 0.46 1.11 0.46
maximum 10.30 13.09 7.17 9.68 7.12 13.09
HOSPITALS 6 16 3 56 26 107
Episodes per hospital (mean) 772 389 633 412 426 438
minimum 505 254 283 258 250 250
maximum 951 604 1015 753 1054 1054
� CHF stands for Congestive Heart Failure
https://doi.org/10.1371/journal.pone.0228425.t001
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Table 2. Factors associated to in-hospital mortality in AMI patients (2009).





Male Ref Ref Ref
Female 1.09 1.08 1.08
(0.99 1.19) (0.98 1.18) (0.98 1.18)
Age
40–49 Ref Ref Ref
50–59 1.68 1.71 1.70
(1.29 2.19) (1.33 2.25) (1.34 2.12)
60–69 2.61 2.63 2.63
(2.03 3.35) (2.08 3.44) (2.10 3.20)
70–80 4.84 4.84 4.87
(3.80 6.18) (3.87 6.24) (3.87 5.91)
Risk score 1
Healthier patients Ref Ref Ref
More complex patients 2.07 2.11 2.12
(1.90 2.27) (1.93 2.30) (1.93 2.33)
Congestive heart failure (CHF)
2.80 2.88 2.84
(2.56 3.07) (2.64 3.14) (2.45 3.24)
Country
Sweden Ref Ref Ref
Denmark 1.36 1.46 1.41
(1.14 1.61) (1.03 2.01) (1.00 1.96)
Portugal 1.78 1.83 1.88
(1.55 2.05) (1.37 2.31) (1.43 2.42)
Slovenia 1.06 1.01 1.07
(0.83 1.36) (0.61 1.85) (0.66 1.80)
Spain 1.36 1.42 1.38
(1.21 1.52) (1.14 1.73) (1.10 1.66)
Hospitals
MOR on patients w/o CHF 1.40 1.42











Patients without CHF 3.59 3.9
Patients with CHF 8.34
Goodness of fit
Bayesian DIC 17384.88 17317.35
Models: Estimations in the basal model are obtained from single-level logistic modelling; estimations of the general
contextual effect are obtained from MLRM modelling hospitals as random effect, by first just modelling a random
intercept, then adding a random slope for patients with CHF. Figures represent Odds Ratios and 95% confidence
intervals, except in the case of hospital estimates where MOR and confidence intervals are used. Note that, while in
the random intercept model there is one value for MOR, in the model with random slope we obtain a different MOR
for patients with and for patients without CHF.
https://doi.org/10.1371/journal.pone.0228425.t002
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3.1. Is the hospital effect consistent between estimations?
Once was the existence of hospital variance and the observation of a better goodness-of-fit of
the model with random slope examined and proved, its residuals were compared. Fig 2 repre-
sents the comparison of the hospital effect for patients without CHF [uoj] and the hospital
effect conditioned to the coexistence of CHF [u2j].
Once hospitals were classified in accordance with their level of performance (high, moder-
ate or low), the agreement in the classification of hospital performance was non-existent
[weighted Kappa Index value of -0,02 (CI95% -0,08 to 0.04)] suggesting a distinct performance
in both groups of patients.
4. Discussion
Assuming the construct validity of AMI case-fatalities as a measure of hospital quality, this per-
formance assessment exercise, based on 46,875 hospital admissions from five countries, shows
that hospital outcomes differ when it comes to specific subgroups of patients, in our case,
patients with CHF. Indeed, the greater MOR for the model including a random slope (i.e.
assuming an interaction term for patients with CHF) reveals a greater influence of “hospital of
treatment” when it comes to the case mortality rates for CHF patients (from MOR 1.42 in
patients without CHF to MOR 1.69 with CHF).
Finally, the lack of correlation between the hospital effects on the non-CHF AMI patients
and AMI patients with CHF (weighted Kappa Index = -0.02), prompts the need for analysing
hospital effects on regular and specific subgroups of patients.
4.1. Caveats with regard to the lack of concordance
Despite the mathematical robustness of the results in terms of goodness-of-fit of the model
and precision, two questions might be challenging the lack of concordance between the hospi-
tal effect on non-CHF vs. CHF AMI patients.
We could hypothesize, for example, that systemic factors could affect the GCE estimations
distinctly, if the number of CHF patients per hospital is uneven across the sample (e.g. because
of biased coding practices, because more complex patients arrive at certain hospitals, or
Fig 2. Comparison of the hospital effect for the patient without CHF and the hospital effect conditioned to CHF
patients. Weighted Kappa Index -0,02 (CI95% -0,08 to 0.04).
https://doi.org/10.1371/journal.pone.0228425.g002
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because of differential expertise in the treatment of more fragile patients between centres).
Although we have reduced this potential risk by excluding the smaller hospitals from the sam-
ple, if those phenomena are true they could have an influence on the estimations of the hospital
contextual effect in the specific subgroup of patients, resulting in a higher risk of death associ-
ated to the hospital of treatment in those hospitals with more CHF patients. Fig 3 showing the
potential correlation between the prevalence of high-risk patients (x axis) and the estimated
risk in terms of u2j(y axis) shows that this is not the case for the hospitals in the sample, ruling
out this possibility.
Another point that could eventually affect the hospital contextual effect differently on non-
CHF vs. CHF patients is the surviving bias in those with no concurrent CHF. Indeed, AMI
patients with concomitant CHF (most of them STEMI cases) are supposed to be more likely to
die within the first 24 hours. In these cases, patients might die in the emergency room. After
analysing the survival curves for both groups of patients, the negligible differences observed in
the first 24 hours after in-hospital admission strongly suggest that under-recording is not likely
happened in our sample [S2 Appendix shows survival curves for each country]. However, as
patients who died in the emergency room are not part of our dataset, we cannot discard some
under-representation in those CHF patients. Whether this fact could imply any bias in the esti-
mation is unknown.
4.2. Implication of the use of random-slope MLRM in hospital
performance assessment
In contrast with single level estimations, MLRM takes into account the multilevel structure of
the variance existing in the data (e.g. patients nested within hospitals), accounting for the
interdependence of patient outcomes within a hospital and allowing a less biased estimation of
uncertainty, providing weighted estimations of average hospital risk (i.e. shrunken residuals)
and allowing a more reliable assessment of the units under study.
As compared to GEE, both MLRM and GEE assume the existence of a GCE assessing hospi-
tal performance. This contextual effect is termed “general” because it reflects the influence of
the hospital context as a whole, without specifying any contextual characteristics other than
the very boundaries that delimit the hospital [36]. This GCE expresses the joint effect of an
array of factors like, for instance, the skills and specialization of the physicians, the available
access to adequate technology as well as the quality of treatment and care in the hospital. In
Fig 3. Correlation between the prevalence of CHF patients and the hospital effect conditioned to those patients
(u2j). This graph contrasts the possibility of a higher hospital contextual effect due to the higher prevalence of CHF
patients admitted in the hospitals in the sample. No positive correlation is observed.
https://doi.org/10.1371/journal.pone.0228425.g003
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such a way, the hospital context may condition patient outcomes beyond individual character-
istics; that is, the same patient might have a different outcome if he or she is treated in a differ-
ent hospital. However, while GEE modelling takes for granted that this GCE can be quantified
by measuring differences between hospital averages only, in MLRM the GCE is measured by
the share of the total patient variance that is between hospital averages; that is, the MLRM does
not dislocate the individual patients from the hospital averages, but rather considers that there
is a distribution of individual outcomes that can be decomposed into two levels of analysis, the
individual and the hospital [9, 12, 14]. Therefore, “hospital effects” (i.e. GCE) are not properly
appraised by studying the differences between hospital averages alone, but by quantifying the
share of the total patient heterogeneity (i.e. variance) that exists at the hospital level [37–39].
To do this, MLRM estimates the hospital variance and its derivatives partition coefficient as a
measure of the hospital GCE. Thus, when studying a specific quality outcome in patients from
different hospitals, the higher the hospital variance, the more relevant is the hospital context to
understanding the differences between patient outcomes [12].
More importantly, unlike other methods used to analyse clustered information (i.e. patients
nested within hospitals) MLRM considers individual-level associations to be hospital-specific
and drops the assumption that individual level associations are the same for all the hospitals.
Consequently, in an extended MLRM with RS, hospital variance, and thereby hospital GCE,
becomes a function of the patients’ heterogeneity. In other words, by including a RS for a spe-
cific subgroup of patients, the hospital effect is not just a function of the very boundaries of the
hospital but also a function of patients’ features of interest (i.e. in our case having CHF). In prac-
tice, for a dichotomous variable, we obtain a hospital variance (i.e. a GCE) for patients without
CHF and a different hospital variance for patients with CHF. This becomes, beyond consider-
ations of interpretation, the analytical advantage of MLRM as opposed to GEE modelling.
4.3. Implications for hospital performance reporting
Some authors have already suggested, while acknowledging the risk of using indirect standard-
ization in hospital performance assessment [20, 22] or in the context of social epidemiology
[23], that not considering patient heterogeneity could lead to an inappropriate assessment of
performance. This paper empirically underpins the need for exploring both the hospital effect
for patients with or without CHF.
Therefore, a clear message is conveyed to those interested in the public reporting of perfor-
mance measures. Beyond the assumption that performance assessment using administrative data
is not a firm diagnostic tool but rather an instrument for screening, reporting mechanisms, more
specifically league tables or funnel plots, [9, 18] should represent hospital performance according
to the results of the MLRM. If the model without a random slope prevails (which is not the case in
our example), a single representation for the average patient might be enough; however, if a
MLRM with random slope better explains the difference in hospital outcomes, then public report-
ing should represent hospital effects separately for specific subgroups of patients.
One last important implication for decision-makers is that MLRM provides a measure of
the effect of size (i.e. to what extent the hospital contextual effect is relevant to the differences
in health outcomes) through a number of statistics (hospital variance, variance partition coeffi-
cients, and MOR) not yielded by the popular indirect standardization methods or the GEE
models. This feature makes MLRM findings more actionable than other approaches.
5. Conclusions
The hospital contextual effect in 107 hospitals from five different European countries was dif-
ferent in non-CHF AMI patients and AMI patients with CHF, suggesting that accounting for
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patient heterogeneity should be a requirement for adequately characterising and reporting
hospital performance.
MLRM is flexible enough to allow the joint analysis of both overall effects and patient-spe-
cific hospital effects, providing accurate estimations of performance as well as a measure of the
actual relevance of the hospital contextual effect.
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